BlackRock Institutional Trust’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.35M Hold
5,017
﹤0.01% 3192
2016
Q3
$1.11M Hold
5,017
﹤0.01% 3252
2016
Q2
$1.94M Buy
5,017
+1,095
+28% +$1.2M ﹤0.01% 3057
2016
Q1
$2.65M Hold
3,922
﹤0.01% 2929
2015
Q4
$4.12M Sell
3,922
-14
-0.4% -$13.9K ﹤0.01% 2815
2015
Q3
$3.41M Sell
3,936
-389
-9% -$325K ﹤0.01% 2896
2015
Q2
$3.08M Sell
4,325
-1,249
-22% -$1.33M ﹤0.01% 2949
2015
Q1
$12.6M Sell
5,574
-38
-0.7% -$64.8K ﹤0.01% 2239
2014
Q4
$5.78M Buy
5,612
+8
+0.1% +$8.55K ﹤0.01% 2668
2014
Q3
$5.93M Buy
5,604
+887
+19% +$1.49M ﹤0.01% 2609
2014
Q2
$11.8M Sell
4,717
-92
-2% -$188K ﹤0.01% 2326
2014
Q1
$9.16M Buy
4,809
+1,084
+29% +$2.56M ﹤0.01% 2473
2013
Q4
$7.97M Buy
3,725
+444
+14% +$1.05M ﹤0.01% 2552
2013
Q3
$7.38M Sell
3,281
-571
-15% -$1.1M ﹤0.01% 2527
2013
Q2
$6.67M Buy
+3,852
New +$6.12M ﹤0.01% 2551

Other funds holding AMPE

BlackRock Institutional Trust's AMPE Position: Q4 2016 in Review

BlackRock Institutional Trust held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q4 2016 at 5,017 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

BlackRock Institutional Trust first reported a position in AMPE in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.6M in Q1 2015. 71 funds tracked by Wall St. Rank hold AMPE as of Q4 2016.

  • BlackRock Institutional Trust held 5,017 shares of Ampio Pharmaceuticals Inc. worth $1.35M as of Q4 2016.
  • BlackRock Institutional Trust left its Ampio Pharmaceuticals Inc. share count unchanged in Q4 2016.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3192 holding.
  • BlackRock Institutional Trust first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Ampio Pharmaceuticals Inc. position peaked at $12.6M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.